Cancer Care Business Exchange

The Cancer Care Business Exchange is a high-level, multistakeholder forum that focuses on the business implications of the changing complexities in cancer care delivery and payment.

Cancer Care Business Breakthroughs

Stop-Loss Insurance, Explained Thumbnail

Videos

Stop-Loss Insurance, Explained

08/07/2023

Featuring John Hennessy, MBA

John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.

John Hennessy, MBA, Valuate...

08/07/2023

Cancer Care Business Exchange

Health Care Sharing Plans, Explained Thumbnail

Videos

Health Care Sharing Programs, Explained

07/25/2023

Featuring John Hennessy, MBA

John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.

John Hennessy, MBA, Valuate...

07/25/2023

Cancer Care Business Exchange

Videos

AI in Cancer Care: Separating Fact from Fiction

07/17/2023

Featuring Ira Klein, MD

CBEx Advisory Board Member Ira Klein, MD, VP of Medical Affairs for Tempus Labs, provides an inside look into featured session "AI in Cancer Care: Separating Fact from Fiction."

CBEx Advisory Board Member Ira...

07/17/2023

Cancer Care Business Exchange

Videos

Perspective on Lessons Learned from Academic Practices Participating in OCM

06/30/2023

Featuring Theresa Dreyer, MPH

Theresa Dreyer, MPH, value-based care team lead for the Association of American Medical Colleges (AAMC), shares further insights from her ASCO 2023 presentation and discusses the benefits and challenges for academic practices participating in...

Theresa Dreyer, MPH, value-based...

06/30/2023

Journal of Clinical Pathways

Videos

How Will the Chemotherapy Shortage Affect Health Policy in the US?

06/22/2023

Alyssa Schatz, MSW, Senior Director of Policy and Advocacy, NCCN, speaks with the Journal of Clinical Pathways about the current chemotherapy shortage affecting cancer treatment in the US.

Alyssa Schatz, MSW, Senior...

06/22/2023

Cancer Care Business Exchange

Videos

The Enhancing Oncology Model: Stakeholder Perspectives on EOM Prelaunch

06/14/2023

Ron Barkley, MS, JD, from the Cancer Center Business Development Group, speaks with Marissa Rivera, MBA, Ventura County Hematology Oncology Specialists; Alexandra Chong, PhD, Center for Medicare & Medicaid Innovation; Barry Russo, MBA,...

Ron Barkley, MS, JD, from the...

06/14/2023

Cancer Care Business Exchange

Videos

Industry Consolidation: Risant Health, A National Network for Value-Based Care

06/06/2023

In this Cancer Care Business Breakthroughs video, Ron Barkley, MS, JD, Cancer Center Business Development Group, is joined by Barry Russo, MBA, The Center for Cancer and Blood Disorders; Erich Mounce, MHA, Oncology Care Partners; Barbara...

In this Cancer Care Business...

06/06/2023

Cancer Care Business Exchange

Feature Interview

Supporting the Employee Journey Through Cancer: Carrum Health and AccessHope’s Partnership

02/06/2023

The Cancer Care Business Exchange is a high-level, multistakeholder forum focusing on the business implications of the changing complexities in cancer care delivery and payment through conversations between those who have interest, influence,...

The Cancer Care Business...

02/06/2023

Journal of Clinical Pathways

Cancer Care Business Breakthroughs Video 2

The Sleeping Giant: Cost of Cancer Rousing Self-Insured Employers

Self-Insured Employers, Explained

01/12/2023

Deirdre Saulet, PhD, Carrum Health, provides an overview of self-insured employers, including a definition of the term, statistics on why more employers are going the self-insured route, and why the cost of cancer care is such a big concern.

Deirdre Saulet, PhD, Carrum...

01/12/2023

Cancer Care Business Exchange

Cancer Care Business Breakthroughs Video 1

The Sleeping Giant: Cost of Cancer Rousing Self-Insured Employers

Supporting the Employee Journey Through Cancer: Carrum Health and AccessHope's Partnership

12/15/2022

Erich Mounce, MHA, Oncology Care Partners, speaks with Dr. Deirdre Saulet, Carrum Health, and Dr. Harlan Levine, AccessHope, to discuss the recently announced partnership between Carrum Health and AccessHope. This partnership aims to help...

Erich Mounce, MHA, Oncology Care...

12/15/2022

Cancer Care Business Exchange

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Recent Stories

Breaking Down Health Care

Why People Should Care About How Health Care Works (Part 1)

07/29/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.

In part one of this two-part...

07/29/2024

Cancer Care Business Exchange

Breaking Down Health Care

Show Me the Medical Evidence

07/15/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.

In this Breaking Down Health...

07/15/2024

Cancer Care Business Exchange

Breaking Down Health Care

What Does Quality Mean in Health Care?

07/01/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.

In this Breaking Down Health...

07/01/2024

Cancer Care Business Exchange

Breaking Down Health Care

The Balance Between Drug Safety and Availability

06/17/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and...

In this Breaking Down Health...

06/17/2024

Cancer Care Business Exchange

Breaking Down Health Care

Medicare for All: Careful What You Wish for

06/03/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the...

In this Breaking Down Health...

06/03/2024

Cancer Care Business Exchange

Cancer Care Business Exchange

Current Issue

Special Reports

Subscribe

Recent Stories

Specialties

Events

Year Round Education

HMP Global Products